nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—SSTR5—Peptide GPCRs—AGTR1—abdominal aortic aneurysm	0.0438	0.0441	CbGpPWpGaD
Vapreotide—SSTR2—Peptide GPCRs—AGTR1—abdominal aortic aneurysm	0.0405	0.0407	CbGpPWpGaD
Vapreotide—TACR1—Peptide GPCRs—AGTR1—abdominal aortic aneurysm	0.0318	0.032	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—P2RY12—abdominal aortic aneurysm	0.0286	0.0287	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—P2RY12—abdominal aortic aneurysm	0.0265	0.0267	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—P2RY12—abdominal aortic aneurysm	0.0264	0.0265	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—P2RY12—abdominal aortic aneurysm	0.0245	0.0246	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.0227	0.0228	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.021	0.0211	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—AGTR1—abdominal aortic aneurysm	0.0206	0.0207	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—AGTR1—abdominal aortic aneurysm	0.019	0.0191	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.0173	0.0174	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.0165	0.0166	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.0161	0.0162	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.016	0.0161	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—AGTR1—abdominal aortic aneurysm	0.0152	0.0152	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—AGTR1—abdominal aortic aneurysm	0.015	0.0151	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.0149	0.015	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—AGT—abdominal aortic aneurysm	0.0145	0.0146	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—NOS2—abdominal aortic aneurysm	0.0141	0.0142	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.0138	0.0139	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—abdominal aortic aneurysm	0.0136	0.0136	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—AGT—abdominal aortic aneurysm	0.0134	0.0135	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.0128	0.0128	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CCL2—abdominal aortic aneurysm	0.0127	0.0128	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.0126	0.0126	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—AGT—abdominal aortic aneurysm	0.0122	0.0123	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.0121	0.0122	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CCL2—abdominal aortic aneurysm	0.0119	0.012	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—AGT—abdominal aortic aneurysm	0.0113	0.0114	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CCL2—abdominal aortic aneurysm	0.011	0.0111	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.0107	0.0107	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—AGT—abdominal aortic aneurysm	0.0105	0.0106	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.0105	0.0106	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—PTGS2—abdominal aortic aneurysm	0.0104	0.0104	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.01	0.0101	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00978	0.00983	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00973	0.00978	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00972	0.00977	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.00955	0.0096	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—NFKB1—abdominal aortic aneurysm	0.00913	0.00918	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MMP9—abdominal aortic aneurysm	0.00909	0.00913	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00902	0.00907	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00898	0.00903	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00888	0.00893	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CCL2—abdominal aortic aneurysm	0.00868	0.00873	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.0082	0.00824	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00801	0.00806	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00765	0.00769	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00741	0.00745	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.0074	0.00743	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—NFKB1—abdominal aortic aneurysm	0.00719	0.00723	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00711	0.00714	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00707	0.00711	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00684	0.00687	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00645	0.00649	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.0061	0.00613	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00595	0.00598	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00582	0.00585	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00563	0.00566	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00561	0.00564	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00549	0.00552	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.0054	0.00543	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00538	0.00541	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00525	0.00527	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00518	0.0052	CbGpPWpGaD
Vapreotide—Desmopressin—PTGS2—abdominal aortic aneurysm	0.00516	1	CrCbGaD
Vapreotide—SSTR2—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00499	0.00501	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00484	0.00487	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00482	0.00484	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00445	0.00447	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00443	0.00446	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00432	0.00435	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00425	0.00427	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00419	0.00421	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00407	0.0041	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00398	0.004	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00393	0.00395	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00392	0.00394	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00386	0.00388	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00381	0.00383	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.0038	0.00382	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00367	0.00369	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00351	0.00353	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.0035	0.00352	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00319	0.00321	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.00313	0.00315	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00309	0.0031	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00304	0.00306	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00295	0.00296	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.00289	0.00291	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00289	0.0029	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00285	0.00286	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00276	0.00278	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00263	0.00264	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00232	0.00233	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.00228	0.00229	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00225	0.00226	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APOE—abdominal aortic aneurysm	0.0022	0.00221	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00207	0.00208	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00207	0.00208	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APOE—abdominal aortic aneurysm	0.00203	0.00204	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.00185	0.00186	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.00173	0.00174	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.00171	0.00172	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00163	0.00164	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.0016	0.00161	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.00159	0.0016	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.00134	0.00135	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.00132	0.00133	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.00131	0.00132	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.00125	0.00126	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.00122	0.00123	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.00121	0.00121	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000961	0.000966	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000951	0.000956	CbGpPWpGaD
